Results

1–10 of 160 results for Retinal Vascular Disease

Reducing Time to Treatment of Retinal Artery Occlusions Using a Remote Diagnostic Protocol
Gareth Lema, MD, PhD
Annual Meeting Talks
2024
Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Annual Meeting Talks
2024
Intraoperative Fluorescein Angiography Reduces the Rate of Postoperative Vitreous Hemorrhage
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2024
Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion: 72-Week Results From the Phase 3 BALATON and COMINO Trials
Carl J Danzig, MD
Annual Meeting Talks
2024
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on the Risk of Retinal Vein and Artery Occlusions
Aleksandra V. Rachitskaya, MD, FASRS
Updates from the Field
2025
The Associated Risk Over Time of Cerebrovascular and Cardiovascular Events in Branch and Central Retinal Artery Occlusions
Robin A Vora, MD
Updates from the Field
2025
Suprachoroidal Hemorrhage
Retina Image Bank: Images of the Week
2024
Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion:72-Week Results From the Phase 3 BALATON and COMINO Trials
Carl J Danzig, MD
Updates from the Field
2024
Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Subclinical Retinal Ischemia in Individuals With Atrial Fibrillation
Mathieu F Bakhoum, MD, PhD
Annual Meeting Talks
2022